Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • Amgen loses in Harbour antibody patent case, ordered to pay $20M+

Amgen loses in Harbour antibody patent case, ordered to pay $20M+

  • June 15, 2026

A federal jury in Delaware has found that Amgen and its acquired Teneobio willfully infringed on an antibody patent held by Harbour Antibodies, a Dutch subsidiary of China’s Harbour BioMed.

Leave A Comment

Fields (*) Mark are Required